Clinical Trial Update: Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes

View source ↗

Summary

An observational study evaluating the safety of Levemir (insulin detemir) in adults with type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED